MediOwl

At MediOwl, we're dedicated to transforming the landscape of healthcare management for individuals facing chronic diseases. Our journey began with a profound commitment to empowering patients on their healthcare path, and now, we're pioneering cutting-edge AI solutions, starting with our flagship product, InflammAid, designed to provide unparalleled support for those battling inflammatory diseases. Recognizing the challenges that living with chronic conditions can bring, we've harnessed the latest advancements in Artificial Intelligence and healthcare technology to create innovative monitoring devices. These devices not only offer real-time health data monitoring but also deliver valuable insights into disease trends, all within a user-friendly, unobtrusive package. While our initial focus is on Rheumatoid Arthritis, InflammAid represents just the beginning of our unwavering commitment to revolutionizing chronic disease management. At MediOwl, we firmly believe that knowledge is the key to empowerment, and we're determined to place that power firmly in the hands of our patients. Our vision is to foster a healthcare system that's more personalized, proactive, and patient-centric. We're thrilled to embark on this journey alongside you and eagerly anticipate the opportunity to empower lives, one patient at a time. Welcome to the future of healthcare monitoring with MediOwl.

Website

www.medi-owl.com

Externer Link zu MediOwl

Branche

Herstellung medizinischer Geräte

Größe

2–10 Beschäftigte

Hauptsitz

Garching, Bavaria

Art

Privatunternehmen

Gegründet

2023